Apogee Therapeutics, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin 931.30%524.23%
EBIT Margin 1,031.30%624.23%
EBITDA Margin 1,031.30%624.23%
Operating Margin 1,031.30%624.23%
Net Margin 931.30%524.28%
FCF Margin 831.35%496.09%
Valuation
Enterprise Value 1,415.84M2,650.65M
Market Capitalization 1,415.84M2,650.65M
Return Ratios
Return on Sales 9.31%5.24%